Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease-Reference-Cited by-同舟云学术

Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease

Published:2022-08-30 Issue:6 Volume:43 Page:1093-1099
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Suga Kensuke^ORCID,Nishiwaki Aya,Nakamura Takayuki^ORCID,Kagami Shin-Ichiro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-022-05196-z.pdf

Reference27 articles.

1. Gianella S, Letendre S (2016) Cytomegalovirus and HIV: a dangerous pas de Deux. J Infect Dis 214(Suppl 2):S67-74. https://doi.org/10.1093/infdis/jiw217

2. Ljungman P, de la Camara R, Robin C et al (2019) Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European conference on infections in Leukaemia (ECIL 7). Lancet Infect Dis 19(8):e260–e272. https://doi.org/10.1016/s1473-3099(19)30107-0

3. Kotton CN, Kumar D, Caliendo AM et al (2018) The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102(6):900–931. https://doi.org/10.1097/TP.0000000000002191

4. Griffiths P, Baraniak I, Reeves M (2015) The pathogenesis of human cytomegalovirus. J Pathol 235(2):288–297. https://doi.org/10.1002/path.4437

5. Yoshihara R, Komai T, Shoda H, Fujio K (2020) Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases. Int J Rheum Dis 23(11):1534–1540. https://doi.org/10.1111/1756-185X.13990

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and risk factors for cytomegalovirus disease in autoimmune inflammatory rheumatic diseases: A nationwide population‐based study in Taiwan;International Journal of Rheumatic Diseases;2024-02

2. Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research;International Journal of Molecular Sciences;2024-01-09

3. A review on cytomegalovirus in patients with autoimmune inflammatory rheumatic diseases: Prevalence, clinical spectrum, treatment, and antiviral prophylaxis;Proceedings of Singapore Healthcare;2024-01

4. Predictive Factors of Cytomegalovirus Viremia during the Clinical Course of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Single Center Observational Study;Journal of Clinical Medicine;2023-01-02